GlobeNewswire

Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme

Share
Company Announcement
No. 30/2021

Copenhagen, 7 June 2021

Transactions in connection with share buy-back programme

On 10 March 2021, Scandinavian Tobacco Group A/S (“STG”) announced that a share buy-back programme of an aggregated price of up to DKK 600 million was launched with the purpose to adjust the Company’s capital structure and meet obligations relating to the Group’s share-based incentive programme.

The buy-back programme is executed in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (the “Market Abuse Regulation”) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules. The share buy-back programme will end no later than 28 February 2022.

The following transactions have been executed from 31 May to 4 June 2021:

Number of sharesAverage purchase price, DKKTransaction value, DKK
Accumulated, last announcement1,141,419141,275,734
31 May 202120,000130.052,601,012
  1 June 202120,000130.302,606,092
  2 June 202120,000130.432,608,610
  3 June 202120,000129.652,593,072
  4 June 202120,000130.822,616,334
Accumulated under the program1,241,419154,300,854

A detailed overview of transactions during the period 31 May – 4 June 2021 is attached to this announcement.

Following the above transactions STG owns a total of 1,824,993 treasury shares, corresponding to 1.88% of the total share capital.

For further information, please contact:
Investors: Torben Sand, Head of Investor Relations,
phone: +45 5084 7222 or torben.sand@st-group.com

Media: Simon Mehl Augustesen, Director of Group Communications,
phone: +1 484-379-8725 or simon.augustesen@st-group.com


Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Incap Corporation: INCAP’S FACTORIES IN INDIA CONTINUE OPERATIONS WITH REDUCED CAPACITY. INCAP’S PREVIOUSLY ANNOUNCED OUTLOOK FOR 2021 REMAINS UNCHANGED.21.6.2021 11:30:00 CEST | Press release

Incap Corporation 21 June 2021 at 12:30 p.m. (EEST) Stock Exchange Release Insider information INCAP’SFACTORIES IN INDIACONTINUE OPERATIONS WITH REDUCED CAPACITY. INCAP’S PREVIOUSLY ANNOUNCED OUTLOOK FOR 2021 REMAINS UNCHANGED. Karnataka state continues the fight against the coronavirus pandemic extending the measures taken to limit for instance social gatherings. The lock-down in Karnataka has been extended until 5 July 2021. However, the state government has given a number of concessions indicating a phased opening up in the coming weeks. Incap’s permission to operate its factories is still in force and the company continues to operate with somewhat reduced capacity following the government guidelines. The closure and the partial operations of the factories in India do not have an impact on the company’s outlook for 2021 published on 21 April 2021. Incap’s previously announced outlook for 2021: Incap estimates that its revenue, operating profit (EBIT) and adjusted operating profit (E

Progress on Brunel share buyback program 202121.6.2021 11:00:00 CEST | Press release

Amsterdam, 21 June 2021 – Brunel International N.V. (Brunel; BRNL), reports the transaction details for the period 14 June 2021 through 18 June 2021 related to its share buyback program announced on 1 June 2021 for an amount up to EUR 1,977,000, and started on 3 June 2021 in order to meet obligations under its performance share plan for senior management (excluding Board of Directors). Detailed information including all individual transactions can be found on https://www.brunelinternational.net/en/share-buyback-program. DateTotal shares repurchasedAverage purchase priceTotal consideration 14/06/2021 8,286 € 11.6138 € 96,231.95 15/06/2021 14,103 € 11.5806 € 163,321.20 16/06/2021 14,861 € 11.5029 € 170,944.60 17/06/2021 10,184 € 11.3922 € 116,018.16 18/06/2021 12,935 € 11.2274 € 145,226.42 Total60,369€ 11.4586€ 691,742.33 This press release contains inside information as meant in clause 7 of the Market Abuse Regulation. Attachment Press Release Share Buyback 2021 progress

Scientific Beta releases new inflation-friendly indices21.6.2021 10:36:33 CEST | Press release

Press Release - Boston, London, Nice, Paris, Singapore, Tokyo, June 21, 2021 Scientific Beta releases new inflation-friendly indices Equity inflation indices are Scientific Beta’s first suite of macroeconomic factor indices Scientific Beta has announced the release of inflation-friendly indices, the Scientific Beta US Inflation indices, its first suite of macroeconomic factor indices. The inflation indices provide long-term equity performance with additional inflation protection compared to a traditional cap-weighted equity index. These indices correspond to a genuinely important subject for institutional investment, because in the event of inflation they procure a higher asset value (surplus) that could offset the impact of inflation on the revenue needs of future pensioners. This capacity to produce strong conditional performance does not result in a high level of tracking error with respect to the cap-weighted benchmark, like with many indices, and ultimately in poor unconditional p

Inbjudan till HMS Networks telefonkonferens för det andra kvartalet 202121.6.2021 10:15:00 CEST | Pressemelding

HMS Networks AB (publ) offentliggör sin rapport för det andra kvartalet 2021 onsdagen den 14 juli 2021 kl. 08.00. Samma dag kl. 09.00 arrangeras en telefonkonferens för press och aktiemarknad, där VD och koncernchef Staffan Dahlström samt finanschef Joakim Nideborn presenterar rapporten. Presentationen hålls på engelska och följs direkt via telefon eller internet. De bilder som används under presentationen kommer att finnas tillgängliga på HMS webbplats före telefonkonferensen. För att delta i telefonkonferensen, ring in eller följ webbpresentationen via länken nedan. SE: +46 8 566 426 93 UK: +44 3333 009 263 US: +16 467 224 956 Länk till webbsändningen Presentation och inspelning av telefonkonferensen kommer sedan att finnas tillgängligt på HMS webbsida. https://www.hms-networks.com/sv/aktieagare För mer information, kontakta: Staffan Dahlström, VD HMS, +46 (0)35 17 29 01 Joakim Nideborn, Finanschef HMS, +46 (0)35 710 6983 HMS Networks AB (publ) är en marknadsledande leverantör av lös

Invitation to HMS Networks’ second quarter 2021 conference call21.6.2021 10:15:00 CEST | Press release

HMS Networks AB (publ) will release its second quarter report 2021 on Wednesday July 14, 2021, at 08.00 CET. On the same day, at 09.00 CET, a conference call will be held for press and analysts, where President and CEO Staffan Dahlström and CFO Joakim Nideborn present the report. The presentation will be held in English and is followed live by telephone or the internet. Slides used in the presentation will be made available on HMS’ website prior to the telephone conference. To participate in the telephone conference, please call or follow the online presentation via the link below. SE: +46 8 566 426 93 UK: +44 3333 009 263 US: +16 467 224 956 Link to webcast The presentation and recording of the telephone conference will be available on HMS’ website after the call. https://www.hms-networks.com/ir For more information, please contact: Staffan Dahlström, CEO HMS, +46 (0)35 17 29 01 Joakim Nideborn, CFO HMS, +46 (0)35 710 6983 HMS Networks AB (publ) is a market-leading provider of solutio

FLSmidth and Carbon8 Systems sign technology partnership to accelerate carbon capture in global cement industry21.6.2021 10:01:15 CEST | Press release

FLSmidth, the international supplier of sustainable solutions and services to the cement industry, has signed a global commercial partnership with UK-based Carbon8 Systems (C8S) to accelerate the cement industry’s Net Zero ambitions. Carbon capture is essential to achieve a sustainable global cement industry – which currently accounts for 7-8% of global carbon emissions - and deliver on FLSmidth’s MissionZero pledge to enable zero emission production by 2030. Working with the UK’s C8S, FLSmidth will use its global network to extend the reach of C8S’ carbon capture and utilisation (CCU) solution. C8S’ technology, already deployed at a VICAT cement plant in France, takes CO2 directly from process gasses and combine it with bypass dust from the production to manufacture a lightweight aggregate which can be used in construction. Carsten Riisberg Lund, Cement President for FLSmidth said: “The cement industry is pursuing every possible solution to reduce its environmental footprint. Carbon c

Centrient Pharmaceuticals boosting statins API manufacturing capacity21.6.2021 10:00:00 CEST | Press release

Rotterdam, The Netherlands, June 21, 2021 (GLOBE NEWSWIRE) -- Summary: Centrient Pharmaceuticals has started production at its newly built statins API manufacturing unit in Toansa, India.With this expansion the company is doubling its production capacity of Atorvastatin and Rosuvastatin, meeting the increased demand for its high-quality uniquely produced statins.Centrient Pharmaceuticals’ statins are one of the most sustainably produced in the industry by eliminating harmful solvents, generating less waste, and a reduced carbon footprint of 32% as compared to traditional manufacturers.Using backward integrated manufacturing methods, and dedicated production facilities, Centrient Pharmaceuticals is able to offer its customers security of supply. Centrient Pharmaceuticals (“Centrient”), the global leader in sustainable antibiotics, next-generation statins and anti-fungals, announced today to have started production at its new statins manufacturing unit. With the building of its second de